EARNEST Partners’s Opko Health OPK Stock Holding History

EARNEST Partners’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-91	Closed	–	–	1218
2018 Q1	$0	Hold	91	–	–	﹤0.01%	1208
2017 Q4	$0	Buy	+91	New	+$528	﹤0.01%	1208
2017 Q1	–	Sell	-91	Closed	-$1K	–	706
2016 Q4	$1K	Buy	+91	New	+$941	﹤0.01%	1054

Other funds holding OPK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

EARNEST Partners's OPK Position: Q2 2018 in Review

EARNEST Partners sold out of Opko Health (OPK) in Q2 2018, closing a stake of 91 shares.

EARNEST Partners first reported a position in OPK in Q4 2016 and held it in 3 quarters. The position peaked at $1K in Q4 2016. 214 funds tracked by Wall St. Rank hold OPK as of Q2 2018.

EARNEST Partners reported no remaining Opko Health position as of Q2 2018 after selling out during the quarter.
EARNEST Partners sold 91 Opko Health shares in Q2 2018.
EARNEST Partners first reported a position in Opko Health in Q4 2016 and held it in 3 quarters.
EARNEST Partners's Opko Health position peaked at $1K in Q4 2016.
214 funds tracked by Wall St. Rank held Opko Health as of Q2 2018.

Based on EARNEST Partners's 13F filing for Q2 2018, filed 13 Aug 2018.